Factors associated with RTS,S vaccination uptake in Northern Ghana, 2021–2022
This study of RTS,S malaria vaccine uptake in Northern Ghana (2021–2022) found high coverage for the first three doses but suboptimal completion of the fourth dose, which was significantly influenced by maternal education, place of delivery, religion, and urban versus rural residence.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Malaria is a relentless threat to children in many parts of Africa, a disease carried by mosquitoes that causes fever, severe illness, and often death. For decades, the primary defense against this parasite has been a combination of bed nets, sprays, and medicine, but these tools alone have not been enough to stop the cycle of infection. In recent years, scientists developed a new weapon: a vaccine designed to teach a child's immune system how to fight the malaria parasite before it can take hold. This vaccine, known as RTS,S, is not a single shot but a series of four doses given over the first two years of a child's life. The first three doses are administered when a baby is roughly six, seven, and nine months old, with a final booster given later, originally scheduled for when the child is two years old. While the vaccine has shown promise in protecting children, the real test lies in whether families actually bring their children in for all four shots. Getting a child to a clinic for a first dose is one thing; keeping them on track for a full series, especially when life gets busy or when the final dose is due much later, is a different challenge entirely.
In the northern part of Ghana, where malaria is a constant presence, researchers set out to understand exactly what helps or hinders families from completing this full vaccination series. They looked at data from thousands of children in a region where health workers have been carefully tracking births, deaths, and vaccinations for years. The team examined records from 2021 and 2022 to see how many children received the first three doses and, more critically, how many returned for the fourth and final dose. They also looked at the lives of the mothers and the circumstances of the children's births to find patterns. The goal was not just to count shots, but to understand the human and logistical reasons why some children got fully protected while others stopped halfway through.
The results showed that the first part of the journey was largely successful. Among children between one and two years old, nearly all had received the first dose, and the vast majority had received the second and third as well. The numbers were high, with about 95 percent of children getting the first shot and 89 percent completing the third. This suggests that when the vaccine is introduced and families are engaged early, the initial uptake is strong. However, the story changed significantly when the researchers looked at the final dose. Among children between two and three years old, only about two-thirds had received that crucial fourth shot. This drop-off meant that a significant number of children were left without the full protection the vaccine was designed to provide, highlighting a gap between the start of the program and its completion.
The study then peeled back the layers to see what factors influenced these outcomes. One of the strongest predictors of a child receiving all three early doses was where the baby was born. Children born in a health facility were much more likely to complete the first three doses than those born at home. This makes sense, as a birth in a clinic often marks the beginning of a relationship with the health system, where mothers receive advice and are reminded of future appointments. In contrast, mothers who gave birth at home, perhaps due to distance or tradition, were less likely to return for the full series. Similarly, the education level of the mother played a role; children whose mothers had completed secondary or higher education were more likely to receive the first three doses than those whose mothers had only basic schooling. This suggests that understanding the schedule and the importance of the vaccine helps families stay on track.
When the researchers turned their attention to the fourth dose, the picture became even more complex. The drop in coverage for this final shot was stark. The study found that children born in a health facility were still more likely to get this dose than those born at home. Religion also emerged as a factor, with children of Christian mothers being more likely to receive the fourth dose compared to those whose mothers practiced traditional African religions. Surprisingly, the location of the home mattered in a way that might seem counterintuitive at first. Children living in rural areas were actually more likely to receive the fourth dose than those living in urban areas. The researchers suggest this might be because malaria is a more immediate and visible threat in rural communities, prompting families to be more diligent, or because rural health programs have strong community networks that help track down children who miss appointments.
The findings paint a clear picture of where the system is working and where it is struggling. The high uptake of the first three doses shows that the vaccine is accessible and accepted when families are engaged early. The significant drop at the fourth dose, however, reveals a vulnerability in the long-term follow-up. The study does not claim to have solved the problem, but it points directly to the specific groups that need more support: families who give birth at home, those with lower levels of maternal education, and those in urban areas where the urgency of malaria might feel less immediate. By focusing on these specific barriers, health officials can design better strategies to ensure that every child who starts the journey with the vaccine finishes it, securing the full protection needed to survive and thrive in a malaria-prone region.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.